Neutral glycosphingolipid expression in B-cell neoplasms
- 1 December 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 49 (6) , 837-845
- https://doi.org/10.1002/ijc.2910490607
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A monoclonal antibody for terminal ?-galactose. Use in analysis of glycosphingolipidsGlycoconjugate Journal, 1991
- Functions of Sphingolipids and Sphingolipid Breakdown Products in Cellular RegulationScience, 1989
- Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.Journal of Clinical Oncology, 1987
- Response to 2'-deoxycoformycin after failure of interferon-alpha in nonsplenectomized patients with hairy cell leukemiaBlood, 1986
- A monoclonal antibody against a Burkitt lymphoma associated antigen has an anti‐Pk red blood cell specificityBritish Journal of Haematology, 1985
- Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.Proceedings of the National Academy of Sciences, 1985
- Monoclonal Antibodies Directed to Cell-Surface CarbohydratesPublished by Springer Nature ,1984
- Gangliosides of Human Chronic Lymphocytic Leukemia and Hairy CellsEuropean Journal of Biochemistry, 1983
- Glycosphingolipids in Cellular Interaction, Differentiation, and OncogenesisPublished by Springer Nature ,1983
- Gangliosides in leukemic and non-leukemic human leukocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972